PS-002 for the Treatment of IgA Nephropathy in Adults

Clinical trial NCT07182227 · RECRUITING

Trial details

NCT number: NCT07182227
Sponsor: Purespring Therapeutics Limited
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Immunoglobulin A (IgA) Nephropathy

Start date: 2026-03-30
Primary completion: 2028-09-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.